Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Hoel, NL; Hansen-Schwartz, J; Edvinsson, L
   Selective up-regulation of 5-HT1B/1D receptors during organ culture of cerebral arteries
   NEUROREPORT
   
   N.L. Hoel et al., "Selective up-regulation of 5-HT1B/1D receptors during organ culture of cerebral arteries", NEUROREPORT, 12(8), 2001, pp. 1605-1608
2. Bolander, FF
   The role of nitric oxide in the biological activity of prolactin in the mouse mammary gland
   MOLECULAR AND CELLULAR ENDOCRINOLOGY
   
   F.F. Bolander, "The role of nitric oxide in the biological activity of prolactin in the mouse mammary gland", MOL C ENDOC, 174(1-2), 2001, pp. 91-98
3. Cabrini, DA; Campos, MM; Tratsk, KS; Merino, VF; Silva, JA; Souza, GEP; Avellar, MCW; Pesquero, JB; Calixto, JB
   Molecular and pharmacological evidence for modulation of kinin B-1 receptor expression by endogenous glucocorticoids hormones in rats
   BRITISH JOURNAL OF PHARMACOLOGY
   
   D.A. Cabrini et al., "Molecular and pharmacological evidence for modulation of kinin B-1 receptor expression by endogenous glucocorticoids hormones in rats", BR J PHARM, 132(2), 2001, pp. 567-577
4. Li, T; Liu, XH; Zhu, ZH; Zhao, JH; Hu, X; Sham, PC; Collier, DA
   Association analysis of polymorphisms in the mu opioid gene and heroin abuse in Chinese subjects
   ADDICTION BIOLOGY
   
   T. Li et al., "Association analysis of polymorphisms in the mu opioid gene and heroin abuse in Chinese subjects", ADDICT BIOL, 5(2), 2000, pp. 181-186
5. Saito, Y; Takashima, S
   Neurotransmitter changes in the pathophysiology of Lesch-Nyhan syndrome
   BRAIN & DEVELOPMENT
   
   Y. Saito e S. Takashima, "Neurotransmitter changes in the pathophysiology of Lesch-Nyhan syndrome", BRAIN DEVEL, 2000, pp. S122-S131
6. Lee, SC; Yoburn, BC
   The effect of nimodipine on opioid antagonist-induced upregulation and supersensitivity
   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
   
   S.C. Lee e B.C. Yoburn, "The effect of nimodipine on opioid antagonist-induced upregulation and supersensitivity", PHARM BIO B, 66(2), 2000, pp. 347-351
7. Bolander, FF
   Regulation of prolactin receptor glycosylation and its role in receptor location
   MOLECULAR AND CELLULAR ENDOCRINOLOGY
   
   F.F. Bolander, "Regulation of prolactin receptor glycosylation and its role in receptor location", MOL C ENDOC, 149(1-2), 1999, pp. 85-92
8. Hyytia, P; Ingman, K; Soini, SL; Laitinen, JT; Korpi, ER
   Effects of continuous opioid receptor blockade on alcohol intake and up-regulation of opioid receptor subtype signalling in a genetic model of high alcohol drinking
   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
   
   P. Hyytia et al., "Effects of continuous opioid receptor blockade on alcohol intake and up-regulation of opioid receptor subtype signalling in a genetic model of high alcohol drinking", N-S ARCH PH, 360(4), 1999, pp. 391-401
9. Ly, LH; Zhao, XY; Holloway, L; Feldman, D
   Liarozole acts synergistically with 1 alpha,25-dihydroxyvitamin D-3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity
   ENDOCRINOLOGY
   
   L.H. Ly et al., "Liarozole acts synergistically with 1 alpha,25-dihydroxyvitamin D-3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity", ENDOCRINOL, 140(5), 1999, pp. 2071-2076
10. Chen, BC; Lin, WW
    PKC beta I mediates the inhibition of P2Y receptor-induced inositol phosphate formation in endothelial cells
    BRITISH JOURNAL OF PHARMACOLOGY
    
    B.C. Chen e W.W. Lin, "PKC beta I mediates the inhibition of P2Y receptor-induced inositol phosphate formation in endothelial cells", BR J PHARM, 127(8), 1999, pp. 1908-1914
11. Holter, SM; Spanagel, R
    Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats
    PSYCHOPHARMACOLOGY
    
    S.M. Holter e R. Spanagel, "Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats", PSYCHOPHAR, 145(4), 1999, pp. 360-369
12. LEHOUEZEC J
    NICOTINE - ABUSED SUBSTANCE AND THERAPEUTIC AGENT
    Journal of psychiatry & neuroscience
    
    J. Lehouezec, "NICOTINE - ABUSED SUBSTANCE AND THERAPEUTIC AGENT", Journal of psychiatry & neuroscience, 23(2), 1998, pp. 95-108
13. UNTERWALD EM; ANTON B; TO T; LAM H; EVANS CJ
    QUANTITATIVE IMMUNOLOCALIZATION OF MU-OPIOID RECEPTORS - REGULATION BY NALTREXONE
    Neuroscience
    
    E.M. Unterwald et al., "QUANTITATIVE IMMUNOLOCALIZATION OF MU-OPIOID RECEPTORS - REGULATION BY NALTREXONE", Neuroscience, 85(3), 1998, pp. 897-905
14. MOLLER S; ADNER M; EDVINSSON L
    INCREASED LEVELS OF ENDOTHELIN ETB RECEPTOR MESSENGER-RNA IN HUMAN OMENTAL ARTERIES AFTER ORGAN-CULTURE - QUANTIFICATION BY COMPETITIVE REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION
    Clinical and experimental pharmacology and physiology
    
    S. Moller et al., "INCREASED LEVELS OF ENDOTHELIN ETB RECEPTOR MESSENGER-RNA IN HUMAN OMENTAL ARTERIES AFTER ORGAN-CULTURE - QUANTIFICATION BY COMPETITIVE REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION", Clinical and experimental pharmacology and physiology, 25(10), 1998, pp. 788-794
15. CAMPOS MM; SOUZA GEP; CALIXTO JB
    MODULATION OF KININ B-1 BUT NOT B-2 RECEPTORS-MEDIATED RAT PAW EDEMA BY IL-1-BETA AND TNF-ALPHA
    Peptides (New York, N.Y. 1980)
    
    M.M. Campos et al., "MODULATION OF KININ B-1 BUT NOT B-2 RECEPTORS-MEDIATED RAT PAW EDEMA BY IL-1-BETA AND TNF-ALPHA", Peptides (New York, N.Y. 1980), 19(7), 1998, pp. 1269-1276
16. SHEN J; SHAH S; HSU H; YOBURN BC
    THE EFFECTS OF ANTISENSE TO G(I-ALPHA-2) ON OPIOID AGONIST POTENCY AND G(I-ALPHA-2) PROTEIN AND MESSENGER-RNA ABUNDANCE IN THE MOUSE
    Molecular brain research
    
    J. Shen et al., "THE EFFECTS OF ANTISENSE TO G(I-ALPHA-2) ON OPIOID AGONIST POTENCY AND G(I-ALPHA-2) PROTEIN AND MESSENGER-RNA ABUNDANCE IN THE MOUSE", Molecular brain research, 59(2), 1998, pp. 247-255
17. CARON RW; LENG G; LUDWIG M; RUSSELL JA
    NALOXONE-INDUCED SUPERSENSITIVITY OF OXYTOCIN NEURONS TO OPIOID ANTAGONISTS
    Neuropharmacology
    
    R.W. Caron et al., "NALOXONE-INDUCED SUPERSENSITIVITY OF OXYTOCIN NEURONS TO OPIOID ANTAGONISTS", Neuropharmacology, 37(7), 1998, pp. 887-897
18. GUZZETTI S; MENNINI T; CAGNOTTO A; DIBIASI P; SCROFANI R; MEZZETTI S; COGLIATI C; PAGLIA S; MALLIANI A
    MYOCARDIAL BETA-ADRENERGIC AND MUSCARINIC RECEPTOR DENSITY IN CARDIACPRESSURE OR VOLUME OVERLOAD
    Journal of Molecular and Cellular Cardiology
    
    S. Guzzetti et al., "MYOCARDIAL BETA-ADRENERGIC AND MUSCARINIC RECEPTOR DENSITY IN CARDIACPRESSURE OR VOLUME OVERLOAD", Journal of Molecular and Cellular Cardiology, 30(10), 1998, pp. 2095-2102
19. LOVATI MR; MANZONI C; GIANAZZA E; SIRTORI CR
    SOYBEAN PROTEIN PRODUCTS AS REGULATORS OF LIVER LOW-DENSITY-LIPOPROTEIN RECEPTORS - I - IDENTIFICATION OF ACTIVE BETA-CONGLYCININ SUBUNITS
    Journal of agricultural and food chemistry
    
    M.R. Lovati et al., "SOYBEAN PROTEIN PRODUCTS AS REGULATORS OF LIVER LOW-DENSITY-LIPOPROTEIN RECEPTORS - I - IDENTIFICATION OF ACTIVE BETA-CONGLYCININ SUBUNITS", Journal of agricultural and food chemistry, 46(7), 1998, pp. 2474-2480
20. MANZONI C; LOVATI MR; GIANAZZA E; MORITA Y; SIRTORI CR
    SOYBEAN PROTEIN PRODUCTS AS REGULATORS OF LIVER LOW-DENSITY-LIPOPROTEIN RECEPTORS - II - ALPHA-ALPHA' RICH COMMERCIAL SOY CONCENTRATE AND ALPHA' DEFICIENT MUTANT DIFFERENTLY AFFECT LOW-DENSITY-LIPOPROTEIN RECEPTOR ACTIVATION
    Journal of agricultural and food chemistry
    
    C. Manzoni et al., "SOYBEAN PROTEIN PRODUCTS AS REGULATORS OF LIVER LOW-DENSITY-LIPOPROTEIN RECEPTORS - II - ALPHA-ALPHA' RICH COMMERCIAL SOY CONCENTRATE AND ALPHA' DEFICIENT MUTANT DIFFERENTLY AFFECT LOW-DENSITY-LIPOPROTEIN RECEPTOR ACTIVATION", Journal of agricultural and food chemistry, 46(7), 1998, pp. 2481-2484
21. SCHRODER J; SILVESTRI S; BUBECK B; KARR M; DEMISCH S; SCHERRER S; GEIDER FJ; SAUER H
    D-2 DOPAMINE-RECEPTOR UP-REGULATION, TREATMENT RESPONSE, NEUROLOGICALSOFT SIGNS, AND EXTRAPYRAMIDAL SIDE-EFFECTS IN SCHIZOPHRENIA - A FOLLOW-UP-STUDY WITH I-123 IODOBENZAMIDE SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY IN THE DRUG-NAIVE STATE AND AFTER NEUROLEPTIC TREATMENT
    Biological psychiatry
    
    J. Schroder et al., "D-2 DOPAMINE-RECEPTOR UP-REGULATION, TREATMENT RESPONSE, NEUROLOGICALSOFT SIGNS, AND EXTRAPYRAMIDAL SIDE-EFFECTS IN SCHIZOPHRENIA - A FOLLOW-UP-STUDY WITH I-123 IODOBENZAMIDE SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY IN THE DRUG-NAIVE STATE AND AFTER NEUROLEPTIC TREATMENT", Biological psychiatry, 43(9), 1998, pp. 660-665
22. THOMAS P; BRECKENRIDGEMILLER D; DETWEILER C
    BINDING CHARACTERISTICS AND REGULATION OF THE 17,20-BETA,21-TRIHYDROXY-4-PREGNEN-3-ONE (20-BETA-S) RECEPTOR ON TESTICULAR AND SPERM PLASMA-MEMBRANES OF SPOTTED SEA-TROUT (CYNOSCION NEBULOSUS)
    Fish physiology and biochemistry
    
    P. Thomas et al., "BINDING CHARACTERISTICS AND REGULATION OF THE 17,20-BETA,21-TRIHYDROXY-4-PREGNEN-3-ONE (20-BETA-S) RECEPTOR ON TESTICULAR AND SPERM PLASMA-MEMBRANES OF SPOTTED SEA-TROUT (CYNOSCION NEBULOSUS)", Fish physiology and biochemistry, 17(1-6), 1997, pp. 109-116
23. IBUKI T; DUNBAR SA; YAKSH TL
    EFFECT OF TRANSIENT NALOXONE ANTAGONISM ON TOLERANCE DEVELOPMENT IN RATS RECEIVING CONTINUOUS SPINAL MORPHINE INFUSION
    Pain
    
    T. Ibuki et al., "EFFECT OF TRANSIENT NALOXONE ANTAGONISM ON TOLERANCE DEVELOPMENT IN RATS RECEIVING CONTINUOUS SPINAL MORPHINE INFUSION", Pain, 70(2-3), 1997, pp. 125-132
24. PHILLIPS TJ; WENGER CD; DOROW JD
    NALTREXONE EFFECTS ON ETHANOL DRINKING ACQUISITION AND ON ESTABLISHEDETHANOL-CONSUMPTION IN C57BL 6J MICE/
    Alcoholism, clinical and experimental research
    
    T.J. Phillips et al., "NALTREXONE EFFECTS ON ETHANOL DRINKING ACQUISITION AND ON ESTABLISHEDETHANOL-CONSUMPTION IN C57BL 6J MICE/", Alcoholism, clinical and experimental research, 21(4), 1997, pp. 691-702
25. ROWELL PP; LI M
    DOSE-RESPONSE RELATIONSHIP FOR NICOTINE-INDUCED UP-REGULATION OF RAT-BRAIN NICOTINIC RECEPTORS
    Journal of neurochemistry
    
    P.P. Rowell e M. Li, "DOSE-RESPONSE RELATIONSHIP FOR NICOTINE-INDUCED UP-REGULATION OF RAT-BRAIN NICOTINIC RECEPTORS", Journal of neurochemistry, 68(5), 1997, pp. 1982-1989
26. BIRD KS; ANDERSON JL; TOEWS ML
    MODULATION OF ALPHA(1B)-ADRENOCEPTOR EXPRESSION BY AGONIST AND PROTEIN-KINASE INHIBITORS
    European journal of pharmacology
    
    K.S. Bird et al., "MODULATION OF ALPHA(1B)-ADRENOCEPTOR EXPRESSION BY AGONIST AND PROTEIN-KINASE INHIBITORS", European journal of pharmacology, 340(2-3), 1997, pp. 267-275
27. BONNER JC; BADGETT A; LINDROOS PM; COIN PG
    BASIC FIBROBLAST GROWTH-FACTOR INDUCES EXPRESSION OF THE PDGF RECEPTOR-ALPHA ON HUMAN BRONCHIAL SMOOTH-MUSCLE CELLS
    American journal of physiology. Lung cellular and molecular physiology
    
    J.C. Bonner et al., "BASIC FIBROBLAST GROWTH-FACTOR INDUCES EXPRESSION OF THE PDGF RECEPTOR-ALPHA ON HUMAN BRONCHIAL SMOOTH-MUSCLE CELLS", American journal of physiology. Lung cellular and molecular physiology, 15(6), 1996, pp. 880-888
28. OGLE CW; GLAVIN GB
    CHRONIC NICOTINE TREATMENT UP-REGULATES MUSCARINIC M(1)-RECEPTORS IN THE RAT STOMACH
    Medical science research
    
    C.W. Ogle e G.B. Glavin, "CHRONIC NICOTINE TREATMENT UP-REGULATES MUSCARINIC M(1)-RECEPTORS IN THE RAT STOMACH", Medical science research, 24(2), 1996, pp. 83-84
29. BALFOUR DJK; FAGERSTROM KO
    PHARMACOLOGY OF NICOTINE AND ITS THERAPEUTIC USE IN SMOKING CESSATIONAND NEURODEGENERATIVE DISORDERS
    Pharmacology & therapeutics
    
    D.J.K. Balfour e K.O. Fagerstrom, "PHARMACOLOGY OF NICOTINE AND ITS THERAPEUTIC USE IN SMOKING CESSATIONAND NEURODEGENERATIVE DISORDERS", Pharmacology & therapeutics, 72(1), 1996, pp. 51-81
30. ALCARAZ C; VARGAS ML; MILANES MV
    CHRONIC NALOXONE-INDUCED SUPERSENSITIVITY AFFECTS NEITHER TOLERANCE TO NOR PHYSICAL-DEPENDENCE ON MORPHINE AT HYPOTHALAMUS PITUITARY-ADRENOCORTICAL AXIS
    Neuropeptides
    
    C. Alcaraz et al., "CHRONIC NALOXONE-INDUCED SUPERSENSITIVITY AFFECTS NEITHER TOLERANCE TO NOR PHYSICAL-DEPENDENCE ON MORPHINE AT HYPOTHALAMUS PITUITARY-ADRENOCORTICAL AXIS", Neuropeptides, 30(1), 1996, pp. 29-36
31. ABDULLA FA; BRADBURY E; CALAMINICI MR; LIPPIELLO PM; WONNACOTT S; GRAY JA; SINDEN JD
    RELATIONSHIP BETWEEN UP-REGULATION OF NICOTINE BINDING-SITES IN RAT-BRAIN AND DELAYED COGNITIVE ENHANCEMENT OBSERVED AFTER CHRONIC OR ACUTENICOTINIC RECEPTOR STIMULATION
    Psychopharmacology
    
    F.A. Abdulla et al., "RELATIONSHIP BETWEEN UP-REGULATION OF NICOTINE BINDING-SITES IN RAT-BRAIN AND DELAYED COGNITIVE ENHANCEMENT OBSERVED AFTER CHRONIC OR ACUTENICOTINIC RECEPTOR STIMULATION", Psychopharmacology, 124(4), 1996, pp. 323-331
32. CONLON D; JOHNSTON A; OMALLEY K; TURNER P; KILFEATHER S
    EFFECT OF AGING AND PROPRANOLOL ADMINISTRATION ON MYOCARDIAL BETA-ADRENOCEPTOR RECEPTOR FUNCTION IN MATURE RATS
    European journal of pharmacology. Molecular pharmacology section
    
    D. Conlon et al., "EFFECT OF AGING AND PROPRANOLOL ADMINISTRATION ON MYOCARDIAL BETA-ADRENOCEPTOR RECEPTOR FUNCTION IN MATURE RATS", European journal of pharmacology. Molecular pharmacology section, 289(2), 1995, pp. 283-290
33. EGAN MF; FERGUSON JN; HYDE TM
    EFFECTS OF CHRONIC NALOXONE ADMINISTRATION ON VACUOUS CHEWING MOVEMENTS AND CATALEPSY IN RATS TREATED WITH LONG-TERM HALOPERIDOL DECANOATE
    Brain research bulletin
    
    M.F. Egan et al., "EFFECTS OF CHRONIC NALOXONE ADMINISTRATION ON VACUOUS CHEWING MOVEMENTS AND CATALEPSY IN RATS TREATED WITH LONG-TERM HALOPERIDOL DECANOATE", Brain research bulletin, 38(4), 1995, pp. 355-363
34. CHEN H; ZHANG L; RUBINOW DR; CHUANG DM
    CHRONIC BUSPIRONE TREATMENT DIFFERENTIALLY REGULATES 5-HT1A AND 5-HT2A RECEPTOR MESSENGER-RNA AND BINDING-SITES IN VARIOUS REGIONS OF THE RAT HIPPOCAMPUS
    Molecular brain research
    
    H. Chen et al., "CHRONIC BUSPIRONE TREATMENT DIFFERENTIALLY REGULATES 5-HT1A AND 5-HT2A RECEPTOR MESSENGER-RNA AND BINDING-SITES IN VARIOUS REGIONS OF THE RAT HIPPOCAMPUS", Molecular brain research, 32(2), 1995, pp. 348-353
35. ADNER M; ERLINGE D; NILSSON L; EDVINSSON L
    UP-REGULATION OF A NON-ET(A) RECEPTOR IN HUMAN ARTERIES IN-VITRO
    Journal of cardiovascular pharmacology
    
    M. Adner et al., "UP-REGULATION OF A NON-ET(A) RECEPTOR IN HUMAN ARTERIES IN-VITRO", Journal of cardiovascular pharmacology, 26, 1995, pp. 314-316
36. UNTERWALD EM; RUBENFELD JM; KREEK MJ
    REPEATED COCAINE ADMINISTRATION UP-REGULATES KAPPA-OPIOID AND MU-OPIOID, BUT NOT DELTA-OPIOID RECEPTORS
    NeuroReport
    
    E.M. Unterwald et al., "REPEATED COCAINE ADMINISTRATION UP-REGULATES KAPPA-OPIOID AND MU-OPIOID, BUT NOT DELTA-OPIOID RECEPTORS", NeuroReport, 5(13), 1994, pp. 1613-1616
37. AZORLOSA JL
    THE EFFECT OF CHRONIC NALTREXONE PRETREATMENT ON ASSOCIATIVE VS NONASSOCIATIVE MORPHINE-TOLERANCE
    Drug and alcohol dependence
    
    J.L. Azorlosa, "THE EFFECT OF CHRONIC NALTREXONE PRETREATMENT ON ASSOCIATIVE VS NONASSOCIATIVE MORPHINE-TOLERANCE", Drug and alcohol dependence, 36(1), 1994, pp. 65-67
38. LEBRETHON MC; NAVILLE D; BEGEOT M; SAEZ JM
    REGULATION OF CORTICOTROPIN RECEPTOR NUMBER AND MESSENGER-RNA IN CULTURED HUMAN ADRENOCORTICAL-CELLS BY CORTICOTROPIN AND ANGIOTENSIN-II
    The Journal of clinical investigation
    
    M.C. Lebrethon et al., "REGULATION OF CORTICOTROPIN RECEPTOR NUMBER AND MESSENGER-RNA IN CULTURED HUMAN ADRENOCORTICAL-CELLS BY CORTICOTROPIN AND ANGIOTENSIN-II", The Journal of clinical investigation, 93(4), 1994, pp. 1828-1833
39. AUDET R; PETITCLERC E; DRAPEAU G; RIOUX F; MARCEAU F
    FURTHER ANALYSIS OF THE UP-REGULATION OF BRADYKININ B-1 RECEPTORS IN ISOLATED RABBIT AORTA BY USING METABOLIC-INHIBITORS
    European journal of pharmacology
    
    R. Audet et al., "FURTHER ANALYSIS OF THE UP-REGULATION OF BRADYKININ B-1 RECEPTORS IN ISOLATED RABBIT AORTA BY USING METABOLIC-INHIBITORS", European journal of pharmacology, 271(2-3), 1994, pp. 551-555
40. BAUMHAKER Y; BENDOR T; BARHAMBURGER R; SARNE Y
    CHARACTERIZATION OF A TRIPLE OPIOID SYSTEM IN THE HUMAN NEUROBLASTOMANMB CELL-LINE
    Brain research
    
    Y. Baumhaker et al., "CHARACTERIZATION OF A TRIPLE OPIOID SYSTEM IN THE HUMAN NEUROBLASTOMANMB CELL-LINE", Brain research, 665(1), 1994, pp. 94-100
41. ALBURGES ME; NARANG N; WAMSLEY JK
    ALTERATIONS IN THE DOPAMINERGIC RECEPTOR SYSTEM AFTER CHRONIC ADMINISTRATION OF COCAINE
    Synapse
    
    M.E. Alburges et al., "ALTERATIONS IN THE DOPAMINERGIC RECEPTOR SYSTEM AFTER CHRONIC ADMINISTRATION OF COCAINE", Synapse, 14(4), 1993, pp. 314-323
42. ALCARAZ C; VARGAS ML; FUENTE T; MILANES MV
    CHRONIC NALOXONE TREATMENT INDUCES SUPERSENSITIVITY TO A MU-AGONIST BUT NOT TO A KAPPA-AGONIST AT THE HYPOTHALAMUS-PITUITARY-ADRENOCORTICALAXIS LEVEL
    The Journal of pharmacology and experimental therapeutics
    
    C. Alcaraz et al., "CHRONIC NALOXONE TREATMENT INDUCES SUPERSENSITIVITY TO A MU-AGONIST BUT NOT TO A KAPPA-AGONIST AT THE HYPOTHALAMUS-PITUITARY-ADRENOCORTICALAXIS LEVEL", The Journal of pharmacology and experimental therapeutics, 266(3), 1993, pp. 1602-1606
43. FEUERSTEIN TJ; MUTSCHLER A; LUPP A; VANVELTHOVEN V; SCHLICKER E; GOTHERT M
    ENDOGENOUS NORADRENALINE ACTIVATES ALPHA(2)-ADRENOCEPTORS ON SEROTONERGIC NERVE-ENDINGS IN HUMAN AND RAT NEOCORTEX
    Journal of neurochemistry
    
    T.J. Feuerstein et al., "ENDOGENOUS NORADRENALINE ACTIVATES ALPHA(2)-ADRENOCEPTORS ON SEROTONERGIC NERVE-ENDINGS IN HUMAN AND RAT NEOCORTEX", Journal of neurochemistry, 61(2), 1993, pp. 474-480
44. LEVESQUE D; HOLTZMAN SG
    THE POTENTIATING EFFECTS OF RESTRAINT STRESS AND CONTINUOUS NALOXONE INFUSION ON THE ANALGESIC POTENCY OF MORPHINE ARE ADDITIVE
    Brain research
    
    D. Levesque e S.G. Holtzman, "THE POTENTIATING EFFECTS OF RESTRAINT STRESS AND CONTINUOUS NALOXONE INFUSION ON THE ANALGESIC POTENCY OF MORPHINE ARE ADDITIVE", Brain research, 617(1), 1993, pp. 176-180